Haplotype Labs
Personalized prevention using genetics and AI
Based based in San Francisco, CA, USA; Remote, Haplotype Labs works in healthcare.
Profile
We're building the HaploHub: a SaaS platform for genetic testing labs, concierge medical practices, and payer/providers to:
* predict disease risk for their patients based on proprietary or publicly available genetic models
* securely host, manage, and interrogate the genetic data of their population
* generate reports and run the most common inference algorithms (phasing, imputation, ibd, etc.) without writing code
Its activity falls under healthcare; the profile below is assembled from public directory data.
Its base of operations is San Francisco, CA, USA; Remote.
The company is listed at the Winter 2024 stage of development.
Its team size is recorded as 1 employees.
Directory analysis
Haplotype Labs builds the HaploHub, a SaaS platform for genetic testing labs, concierge medical practices, and payers/providers. The platform predicts disease risk using genetic models, securely hosts and manages genetic data, and runs common inference algorithms such as phasing, imputation, and IBD without code. It targets healthcare providers looking to integrate genetic insights into patient care workflows.
Positioning: The company positions itself at the intersection of genomics and healthcare IT, offering a low-code solution for data management and risk prediction. Its market focus on labs and concierge practices suggests a niche but growing demand for integrated genetic analytics.
Note: Haplotype Labs provides a no-code platform for genetic data analysis and risk prediction.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA; Remote |
| Country | USA; Remote |
| Employees | 1 |
| Stage | Winter 2024 |
Website: www.haplotypelabs.com
Browse related
Create a free account